Toronto, Ontario–(Newsfile Corp. – Le 2 février/February 2026) – Mydecine Innovations Group Inc. (MYCO) has announced a name and symbol change to Noveris Health Sciences Inc. (NVRS). Shares will begin trading under the new name and symbol and with a new CUSIP number on February 3, 2026. Disclosure documents are …
Read More »Sharp Therapeutics Announces Private Placement of up to US$3.0 Million in Unsecured Convertible Notes
Pittsburgh, Pennsylvania and Toronto, Ontario–(Newsfile Corp. – February 2, 2026) – Sharp Therapeutics Corp. (TSXV: SHRX) (OTCQB: SHRXF) (“Sharp” or the “Company“) is pleased to announce the terms of a proposed non-brokered private placement for an aggregate principal amount of up to US$3.0 million of unsecured convertible notes of the …
Read More »Arya Resources Announces Long, Continuous Gold Mineralization with Silver Credits at the Twin Zone, Wedge Lake Gold Project, Saskatchewan
Vancouver, British Columbia–(Newsfile Corp. – February 2, 2026) – Arya Resources Ltd. (TSXV: RBZ) (“Arya” or the “Company”) is pleased to report weighted average gold (Au) and silver (Ag) assay results for drill holes AR25-007, AR25-008 and AR25-009 completed at the Twin Zone of its Wedge Lake Gold Project in …
Read More »Thiogenesis Therapeutics Announces Investigator-Initiated Study in Nephropathic Cystinosis and Provides Program Update
San Diego, California–(Newsfile Corp. – February 2, 2026) – Thiogenesis Therapeutics, Corp. (TSXV: TTI) (OTCQX: TTIPF) (“Thiogenesis” or the “Company”), a clinical-stage biotechnology company developing next-generation sulfur-based prodrugs for rare pediatric diseases, today provided an update on its nephropathic cystinosis program and announced a new investigator-initiated study (IIS) collaboration with …
Read More »Adia Nutrition Inc. Announces Dr. Brian Browning as Lead Physician for All Orthopedic Treatments and Specialties at Adia Med
Winter Park, Florida–(Newsfile Corp. – February 2, 2026) – Adia Nutrition Inc. (OTCQB: ADIA), a leader in regenerative medicine, stem cell therapies, and premium wellness solutions through its Adia Med division, is pleased to announce that Dr. Brian L. Browning, DO, a board-certified expert in family medicine and neuromusculoskeletal medicine, …
Read More »Golden Age Announces Closing of Shares for Debt Transaction
Vancouver, British Columbia–(Newsfile Corp. – February 2, 2026) – Golden Age Exploration Ltd. (CSE: GDN) (the “Company“) (“Golden Age“) is pleased to announce that it has closed the Debt Settlement transaction previously announced in its News Release dated January 26, 2026 (the “Debt Settlement”). Under the terms of the Debt Settlement agreements, …
Read More »Early Warning Disclosure – Ownership Exceeding 10%
Toronto, Ontario–(Newsfile Corp. – February 2, 2026) – WWB Holding Ltd. and Bin Wang (collectively, the “Acquiror“) announce that they have acquired beneficial ownership and control over 3,857,000 common shares of Everybody Loves Languages Corp. (TSXV: ELL) (“ELL” or the “Company”) through open market purchases. This holding represents approximately 10.82% …
Read More »Sigma Lithium Announces the Resumption of Mining Activities at Mine 1, with over 600 People Working on Site
HIGHLIGHTS Sigma Lithium announces the resumption of mining activities at its Mine 1 in Vale do Jequitinhonha in Brazil, as scheduled. This step successfully concludes the restructuring of mining operations aimed at increasing safety and operating efficiency, with the Company’s technical leadership managing mining activities and planning, while incorporating a …
Read More »PharmaTher Launches Strategic Initiative to Pursue Health Canada Approval for Generic Semaglutide in Canada, Building on FDA-Approved Ketamine Success
Toronto, Ontario–(Newsfile Corp. – February 2, 2026) – PharmaTher Holdings Ltd. (CSE: PHRM) (OTCQB: PHRRF) (the “Company” or “PharmaTher”), a specialty pharmaceutical company, today announced a new strategic initiative to pursue Health Canada approval for generic semaglutide in Canada and, subject to regulatory approval, its commercialization. Semaglutide is the active …
Read More »Hempalta Corp. Announces AGM, Proposed Corporate Name Change, Financing Update, Audit Committee Composition and Filing of Annual Financial Statements
Calgary, Alberta–(Newsfile Corp. – February 2, 2026) – Hempalta Corp. (TSXV: HEMP) (the “Company”) announces that its Board of Directors has approved the calling of the Company’s annual general meeting of shareholders (the “AGM”), to be held on April 9, 2026, in Calgary, Alberta. Further details regarding the AGM, including …
Read More »
Matribhumi Samachar English